Skip to main content

Martin v. Abbott Laboratories

Citations

  • 689 P.2d 368
  • 102 Wash. 2d 581

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • noting that the Meisel court concluded \successor liability was inapplicable because there had been no transfer of assets\
  • adopting \modified market share\ liability, in which plaintiff must join only one defendant who produced or marketed injury-causing product and then shifting the burden to the defendant to prove its percentage share of market and thereby lower presumptive equal share of market
  • adopting \modified market share\ liability, in which plaintiff must join only one defendant who produced or marketed injury-causing product and then shifting the burden to the defendant to prove its percentage share of market and thereby lower presumptive equal share of market
  • defendants in DES case entitled to exculpate themselves from liability by establishing they did not market in geographic area where plaintiffs mother obtained the drug
  • “The number of firms marketing DES has fluctuated considerably over the years. Estimates are that up to 200 or 300 companies manufactured and marketed DES between 1947 and 1971.”
  • plaintiff only has to sue one defendant that manufactured the product

Source: CourtListener parenthetical corpus (CC0).

Judges: Dore

Read full opinion on CourtListener

Cited by

107 cases in this archive cite this case; the 20 most cited are listed.

Cites

38 cases in this archive are cited by this case; the 20 most cited are listed.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.